These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 20350487)
1. Emerging role of microRNAs in prostate cancer: implications for personalized medicine. Gandellini P; Folini M; Zaffaroni N Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487 [TBL] [Abstract][Full Text] [Related]
3. Towards the definition of prostate cancer-related microRNAs: where are we now? Gandellini P; Folini M; Zaffaroni N Trends Mol Med; 2009 Sep; 15(9):381-90. PubMed ID: 19716766 [TBL] [Abstract][Full Text] [Related]
4. Widespread deregulation of microRNA expression in human prostate cancer. Ozen M; Creighton CJ; Ozdemir M; Ittmann M Oncogene; 2008 Mar; 27(12):1788-93. PubMed ID: 17891175 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in biological processes and carcinogenesis. Osada H; Takahashi T Carcinogenesis; 2007 Jan; 28(1):2-12. PubMed ID: 17028302 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs and cancer: current state and future perspectives in urologic oncology. Schaefer A; Jung M; Kristiansen G; Lein M; Schrader M; Miller K; Stephan C; Jung K Urol Oncol; 2010; 28(1):4-13. PubMed ID: 19117772 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA profile analysis of human prostate cancers. Tong AW; Fulgham P; Jay C; Chen P; Khalil I; Liu S; Senzer N; Eklund AC; Han J; Nemunaitis J Cancer Gene Ther; 2009 Mar; 16(3):206-16. PubMed ID: 18949015 [TBL] [Abstract][Full Text] [Related]
8. MiRNAs as biomarkers and therapeutic targets in cancer. Heneghan HM; Miller N; Kerin MJ Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics. Gordanpour A; Nam RK; Sugar L; Seth A Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688 [TBL] [Abstract][Full Text] [Related]
10. MicroRNAs: novel regulators in the hallmarks of human cancer. Ruan K; Fang X; Ouyang G Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Lowery AJ; Miller N; McNeill RE; Kerin MJ Clin Cancer Res; 2008 Jan; 14(2):360-5. PubMed ID: 18223209 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and prostate cancer. Coppola V; De Maria R; Bonci D Endocr Relat Cancer; 2010 Mar; 17(1):F1-17. PubMed ID: 19779034 [TBL] [Abstract][Full Text] [Related]
13. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Ahmed FE Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs and cancer--new paradigms in molecular oncology. Negrini M; Nicoloso MS; Calin GA Curr Opin Cell Biol; 2009 Jun; 21(3):470-9. PubMed ID: 19411171 [TBL] [Abstract][Full Text] [Related]
16. [Application of microRNAs to Cancer Therapy]. Iguchi H; Ochiya T Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672 [TBL] [Abstract][Full Text] [Related]